Hamilton Lane Advisors LLC Buys New Shares in Doximity, Inc. (NASDAQ:DOCS)

Hamilton Lane Advisors LLC purchased a new position in shares of Doximity, Inc. (NASDAQ:DOCS) in the 4th quarter, Holdings Channel reports. The firm purchased 26,072 shares of the company’s stock, valued at approximately $1,392,000. Doximity accounts for about 1.3% of Hamilton Lane Advisors LLC’s investment portfolio, making the stock its 10th biggest holding.

A number of other large investors also recently bought and sold shares of the stock. Farther Finance Advisors LLC raised its holdings in shares of Doximity by 324.2% in the 3rd quarter. Farther Finance Advisors LLC now owns 789 shares of the company’s stock worth $34,000 after purchasing an additional 603 shares during the period. Quarry LP increased its position in Doximity by 101.2% during the 2nd quarter. Quarry LP now owns 1,616 shares of the company’s stock worth $45,000 after purchasing an additional 131,253 shares in the last quarter. Morse Asset Management Inc purchased a new position in Doximity in the third quarter valued at approximately $46,000. GAMMA Investing LLC grew its stake in Doximity by 40.1% during the third quarter. GAMMA Investing LLC now owns 1,439 shares of the company’s stock worth $63,000 after buying an additional 412 shares during the period. Finally, Covestor Ltd increased its holdings in Doximity by 441.9% in the 3rd quarter. Covestor Ltd now owns 1,680 shares of the company’s stock valued at $73,000 after purchasing an additional 1,370 shares in the last quarter. Hedge funds and other institutional investors own 87.19% of the company’s stock.

Doximity Trading Up 4.4 %

DOCS opened at $53.02 on Thursday. The business’s 50 day moving average is $53.40 and its 200-day moving average is $42.09. The stock has a market cap of $9.90 billion, a PE ratio of 60.94, a price-to-earnings-growth ratio of 4.13 and a beta of 1.38. Doximity, Inc. has a twelve month low of $22.96 and a twelve month high of $61.75.

Analyst Upgrades and Downgrades

Several analysts have issued reports on the company. Raymond James restated an “outperform” rating and set a $65.00 price objective (up previously from $37.00) on shares of Doximity in a research note on Friday, November 8th. Bank of America raised their price objective on Doximity from $54.00 to $57.00 and gave the stock a “neutral” rating in a research note on Monday, January 6th. Canaccord Genuity Group reaffirmed a “hold” rating and issued a $60.00 price objective (up previously from $40.00) on shares of Doximity in a report on Wednesday, November 13th. Truist Financial increased their target price on shares of Doximity from $35.00 to $49.00 and gave the stock a “hold” rating in a report on Thursday, November 14th. Finally, KeyCorp decreased their price target on shares of Doximity from $70.00 to $65.00 and set an “overweight” rating for the company in a report on Wednesday, January 8th. Thirteen research analysts have rated the stock with a hold rating, six have given a buy rating and one has assigned a strong buy rating to the company. According to data from MarketBeat.com, Doximity presently has a consensus rating of “Hold” and an average target price of $53.12.

About Doximity

Doximity, Inc operates a cloud-based digital platform for medical professionals in the United States. The company's platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers.